简体中文 | 繁體中文 | English

新聞稿中心

2018-12-04 09:54 Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018
2018-12-04 09:52 Kyriba Continues to Expand its #1 Global Solutions Ecosystem with New WorldFirst Partnership
2018-12-04 09:50 Vitruvias Therapeutics Inc.和祥翊製藥宣佈FDA核准氨基已酸500毫克和1000毫克錠劑學名藥
2018-12-03 17:37 Char Popp加入PSB擔任資深副總裁兼全球質性研究主管
2018-12-03 16:05 FPT Television選擇Telaria用於其聯網電視資源的程式化管理和貨幣化
2018-12-03 15:07 阿拉伯聯合大公國支持一項史無前例的計畫
2018-12-03 14:56 MIRAI DINING Co., Ltd.:KYOTO MISO RAMEN KAZU於2018年12月1日開業
2018-12-03 10:47 GVIDO MUSIC,兼任社長(總經理)的通知
2018-12-03 10:35 2EASY為企業推薦專業服務商 將拓展亞洲市場
2018-12-03 10:31 東京瓦斯改由Rimini Street為SAP應用軟體提供支援服務
2018-12-03 10:28 Celgene Corporation Announces Results of AUGMENT Evaluating REVLIMID® In Combination with Rituximab (R2) In Patients with Relapsed/Refractory Indolent Lymphoma At ASH 2018
2018-12-03 10:26 Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 MEDALIST Trial Evaluating Luspatercept in Patients with Myelodysplastic Syndromes at the ASH 2018 Plenary Session
2018-12-03 10:24 Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018
2018-12-03 10:22 Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018
2018-12-03 09:30 Citco推出CitcoConnect:針對安全資料共享和數位投資的全新獨立解決方案
2018-11-30 18:11 Cisive宣佈收購Blue Umbrella的聘任前篩選(PES)業務
2018-11-30 18:08 AerSale收購Avborne以擴充MRO能力
2018-11-30 17:45 Andersen Global宣佈擴大全球董事會規模
2018-11-30 15:10 Brightline Initiative研究確認危機模式學習可帶來更強的策略執行能力
2018-11-30 14:39 瞄準中國青年的錢包:9兆美元數位青年震盪